Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     

  • Bitcoin GBP

    50,190.11
    -1,108.82 (-2.16%)
     

  • CMC Crypto 200

    1,314.21
    -82.33 (-5.89%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Company News For Nov 14, 2017

Zacks Equity Research
Updated
Is (AMTD) Outperforming Other Finance Stocks This Year?

  • Shares of Tyson Foods, Inc. TSN gained almost 2% after posting fourth quarter 2017 earnings per share of $1.43, surpassing the Zacks Consensus Estimate of $1.38

  • JD.com, Inc.’s JD shares advanced 3.5% after posting third quarter 2017 earnings of $0.10 a share, surpassing the Zacks Consensus Estimate of a loss of $0.02

  • Shares of Nektar Therapeutics NKTR gained 14.2% after announcing positive results from a Pivot-02 phase 1/2 study of a cancer treatment trial

  • GGP Inc.’s GGP shares gained 8.3% after Brookfield Property Partners made an offer of $14.8 billion to acquire the company


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
JD.com, Inc. (JD) : Free Stock Analysis Report
 
Tyson Foods, Inc. (TSN) : Free Stock Analysis Report
 
Nektar Therapeutics (NKTR) : Free Stock Analysis Report
 
General Growth Properties, Inc. (GGP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research